1 |
Lloyd CE, Orchard TJ. Physical and psychological well-being in adults with Type 1 diabetes. Diabetes Res Clin Pract 1999;44:9-19.
DOI
|
2 |
Dunne TF, Geberhiwot T, Jones R. Acute psychosis in glycogen storage disease: a rare but severe complication. BMJ Case Rep 2019;12:e222307.
DOI
|
3 |
Storch E, Keeley M, Merlo L, Jacob M, Correia C, Weinstein D. Psychosocial functioning in youth with glycogen storage disease type I. J Pediatr Psychol 2008;33:728-38.
DOI
|
4 |
Labrune P, Huguet P, Odievre M. Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients. Pediatr Cardiol 1991;12:161-3.
DOI
|
5 |
Raben N, Sherman JB. Mutations in muscle phosphofructokinase gene. Hum Mutat 1995;6:1-6.
DOI
|
6 |
Mogahed EA, Girgis MY, Sobhy R, Elhabashy H, Abdelaziz OM, El-Karaksy H. Skeletal and cardiac muscle involvement in children with glycogen storage disease type III. Eur J Pediatr 2015;174:1545-8.
DOI
|
7 |
Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. In: Goldman L, Schafer AI, eds. Goldman's Cecil medicine. 24th ed. Vol. 2. Philadelphia: Elsevier/Saunders, 2012:1354-7.
|
8 |
Stark HP. Permission for using Stark QoL questionnaire [Internet]. Message to: Heba Safar.hebasafar97@ gmail.com. 2020 Jan 16. [3 paragraphs].
|
9 |
Hardt J. A new questionnaire for measuring quality of life - the Stark QoL. Health Qual Life Outcomes 2015;13:174.
DOI
|
10 |
Preisler N, Pradel A, Husu E, Madsen KL, Becquemin MH, Mollet A, et al. Exercise intolerance in Glycogen Storage Disease Type III: weakness or energy deficiency? Mol Genet Metab 2013;109:14-20.
DOI
|
11 |
Wolf CM, Arad M, Ahmad F, Sanbe A, Bernstein SA, Toka O, et al. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations. Circulation 2008;117:144-54.
DOI
|
12 |
Hoffmann GF, Smit PA, Schoser B. Glycogen storage diseases of all types. J Inherit Metab Dis 2015;38:389-90.
DOI
|
13 |
Apers S, Kovacs AH, Luyckx K, Thomet C, Budts W, Enomoto J, et al. Quality of life of adults with congenital heart disease in 15 countries: evaluating country-specific characteristics. J Am Coll Cardiol 2016;67:2237-45.
|
14 |
Lu C, Qiu Z, Sun M, Wang W, Wei M, Zhang X. Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations. J Hum Genet 2016;61:641-5.
DOI
|
15 |
Fernandes J, Pikaar NA. Hyperlipemia in children with liver glycogen disease. Am J Clin Nutr 1969;22:617-27.
DOI
|
16 |
Myleus A, Petersen S, Carlsson A, Hammarroth S, Hogberg L, Ivarsson A. Health-related quality of life is not impaired in children with undetected as well as diagnosed celiac disease: a large population based cross-sectional study. BMC Public Health 2014;14:425.
DOI
|
17 |
Hardt J. A new questionnaire for measuring quality of life - the Stark QoL. Health Qual Life Outcomes 2015;13:174.
DOI
|
18 |
Endo Y, Fateen E, El Shabrawy M, Aoyama Y, Ebara T, Murase T, et al. Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId. Clin Chem Lab Med 2009;47:1233-8.
|